Dose-limiting myelosuppression associated with high-dose cisplatin (200 mg/m2) in hypertonic saline

Cancer Treat Rep. 1986 Jun;70(6):820-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cisplatin / administration & dosage*
  • Cisplatin / adverse effects
  • Cisplatin / blood
  • Drug Administration Schedule
  • Drug Evaluation
  • Hematologic Diseases / chemically induced*
  • Humans
  • Lung Neoplasms / drug therapy

Substances

  • Cisplatin